Bi-Specific MAbS Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 25
SKU : PH3460
excelpdfpowerpoint
180 pages
Report Summary
Table of Contents
List of Tables & Figures
loading
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Proceed to Buy
Request new version
FAQ’s
Which region dominates the global Bi-Specific MAbS market ?
North America region will dominate the Bi-Specific MAbS market
Who are the key players in Bi-Specific MAbS market ?
Major players are Amgen, Inc., Bayer AG, Dow Pharmaceutical Solutions, ImmunGene, Inc., Immunocore Limited, Merck & Co., Inc., Novartis AG, Pfizer, Inc., F. Hoffmann-La Roche AG, Hengrui Medicine, SYSVAX and Hisun Pharmaceutical.
Related Reports
pharmaceuticals

Viscosupplementation Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 10
Starting from

$4350

pharmaceuticals

Bronopol Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 10
Starting from

$4350

pharmaceuticals

Pigmentation Disorder Treatment Market Size, Share, Forecast and outlook (2024-2031)

Published: 2024 January 10
Starting from

$4350